Nektar Therapeutics
NKTR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 9.2% | -2.1% | -9.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 68.8% | 59.3% | 76.5% | 75.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -88.1% | -269.8% | -351.8% | -453.2% |
| Net Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | -120.9% | -306.3% | -400% | -514% |
| EPS Diluted | -8.68 | -21.79 | -29.51 | -42.9 |
| % Growth | 60.2% | 26.2% | 31.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |